The Audi Group in the fiscal year 2011: new records for deliveries, revenue and profit (mit Bild)
Ein Dokument
mehr
Storys zum Thema Finanzen
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Fresenius achieves record Q3 earnings - improves 2011 earnings outlook
Bad Homburg (ots) - Q1-3 2011: - Sales EUR 12.1 billion, +2% at actual rates, +5% in constant currency - EBIT EUR 1,862 million, +5% at actual rates, +9% in constant currency - Net income EUR 565 million, +14% at actual rates, +17% in constant currency - Fresenius improves 2011 earnings1 outlook of 15% ...
Ein DokumentmehrARAG Rechtsschutz Plans Conversion: Operative Holding Company to become a Societas Europeae (SE)
Düsseldorf (ots) - ARAG Allgemeine Rechtsschutz-Versicherungs-AG has initiated the process of converting to a "Societas Europeae" (SE). The Management Board has approved the corresponding conversion plan. The operational holding company of the ARAG Group is to be reincorporated as an SE in the course of 2011. Group ...
mehrTrends in Telecoms Change our Lives
Barcelona, Spain, February 17, 2010 (ots/PRNewswire) - About 50-thousand telecoms and media professionals are expected to gather in Barcelona, Spain this week for the GSMA Mobile World Congress. Ericsson is presenting its telecoms vision and latest solutions there. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/ericsson/40785 "The industry is defining a lot of our futures," says ...
mehrBoehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 (Tovok(TM)) as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients With EGFR Mutations
Ingelheim, Germany (ots/PRNewswire) - - Data From Phase II Studies Investigating BIBW 2992 (Tovok(TM)) and BIBF 1120 (Vargatef(TM)) in NSCLC Patients Presented at 13th World Conference on Lung Cancer (WCLC) INGELHEIM, Germany, August 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International ...
mehrNo Increased Risk of Treatment-Induced Augmentation in Restless Legs Syndrome (RLS) Demonstrated in Long-Term Placebo-Controlled Study With Mirapexin(R) / Sifrol(R) (Pramipexole)
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media outside the U.S.A. New data presented today at the 61st Annual Meeting of the American Academy of Neurology (AAN), in Seattle, U.S.A. show that augmentation did not significantly differ in RLS patients treated with Mirapexin(R) /Sifrol(R) (pramipexole*) ...
mehr
Volvo Goes 'Live' at Detroit Auto Show
Gothenburg, Sweden (ots/PRNewswire) - - Volvo will Broadcast and Webcast Live from the North American International Auto Show - January 11, 2009. - "We will create an historic one-hour live TV show to be broadcast throughout North America and simultaneously presented on the World Wide Web. Media from around the world will be able to watch presentations from the Volvo display in Detroit while asking questions in real time ...
mehrTelmisartan (MICARDIS(R)) as Effective as Ramipril But With Better Long-Term Tolerability in High-Risk Cardiovascular Asian Patients
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart attack, ...
mehrData Presented at International AIDS Society (IAS) Conference Shows Long-Term Viramune(R) (nevirapine) Efficacy and Increase in Good Cholesterol
Sydney, Australia (ots/PRNewswire) - New data from two new studies of Viramune(R) (nevirapine) were presented at the 4th International AIDS Society (IAS) in Sydney, Australia. Results from an extended three-year follow-up analysis of the 2NN study demonstrated that HIV-positive patients taking ...
mehrProSiebenSat.1 Group's Revenues and Earnings Grow in Q1 2007
Munich (ots) - - Consolidated revenues up 7.7 percent to EUR 501.2 million - EBITDA up 16.1 percent to EUR 82.0 million - Pre-tax profit up 34.7 percent to EUR 67.5 million - Consolidated profit up 32.2 percent to EUR 40.6 million - Growth driven by higher TV advertising revenues and new business models - Positive outlook for fiscal 2007 The ProSiebenSat.1 Group got fiscal 2007 off to a ...
mehrNordex entering Turkish market for the first time / First major project worth EUR 39 million awarded
Hamburg (ots) - ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Nordex AG has entered the Turkish market on a very successful note: Up until the end of March 2008 it will be assembling 17 N90/2500 HS (high speed) turbines with 80 meters hub ...
mehrUSU Software achieves earnings level of previous year after nine months
Möglingen (ots) - - International share in higher Group revenues increased further - Cost increase remains low, despite higher number of employees - Expansion of product business pushes earnings growth - Financing solid with high liquidity and equity ratio - Group profits to exceed EUR 3 million in 2007 USU Software AG (ISIN DE000A0BVU28) ...
mehr
Miele records 12% growth / Sales in 2005/2006 fiscal year total EUR 2.54 bn / Market leadership as premium brand consolidated
Gütersloh (ots) - During the past reporting period, the family-owned Miele company succeeded in expanding its position throughout the world as unchallenged market leader and premium marque. The five-strong Miele board of management is proud to present record results for the 2005/2006 financial year ending June ...
mehrSinnerSchrader: Third quarter confirms earnings expectation for 2005/2006 - Revenue Growth Slower than Planned
Hamburg, Germany (ots) - In the first nine months of the 2005/2006 financial year, SinnerSchrader earned revenue of EUR 11.7 million, i.e. 11 per cent more than in the comparable period of the previous year. The EBITA rose from EUR 67,000 in the previous year to EUR 380,000. In the third quarter revenue grew from ...
mehrKlöckner & Co launches investor roadshow
Frankfurt (ots) - * Capital increase with net proceeds of around ¤100 million for further improvement of capital structure and generating additional headroom for growth * Around 50 per cent free float after IPO * First day of trading before summer break Klöckner & Co AG management will present the company during a roadshow to national and international investors, which will start on June ...
mehrKlöckner & Co ready for listing on the stock exchange
Duisburg (ots) - The steel and metal distribution company, Klöckner & Co AG, is aiming for a listing on the Prime Standard of the Frankfurt Stock Exchange before the summer break. This will be subject to a favourable capital market environment. "We have thoroughly examined this step. A direct access to the capital market opens up additional flexibility for the future development of our company", said the Chairman of ...
mehrUSU generates significant increase in sales and earnings
Möglingen (ots) - - Significant expansion in product business - Moderate increase in Group costs - Earnings growth exceeds sales growth - Continued solid balance sheet structure - Management Board confirms forecasts USU Software AG and its subsidiaries (referred to below as: "USU Group" or "USU") increased its year-on-year Group sales by EUR 890 k (18.5%) to EUR 5,694 k (PY: EUR 4,804 k) in the ...
mehrBASF Commences US$37 Per Share Cash Tender Offer for Engelhard
Ludwigshafen, Germany (ots) - BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, today announced that it is commencing a cash tender offer for all of the outstanding shares of common stock of Engelhard Corporation (NYSE: EC) for US$37.00 net per share. BASF's price represents a 23% premium above the December 20, 2005 closing price of Engelhard's ...
mehr
BASF Makes All-Cash Proposal To Acquire Engelhard
Ludwigshafen, Germany (ots) - * BASF Intends To Offer US$37.00 Per Share For a Total of US$4.9 Billion * Acquisition Would Make BASF a Leading Provider in the Global Catalyst Business BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, has made an all-cash proposal to acquire all outstanding shares of common stock of Engelhard ...
mehrGreen shoe option for Thielert successfully exercised
Frankfurt, Hamburg (ots) - In relation to the Initial Public Offering of Thielert Aktiengesellschaft (ISIN DE0006052079 / security ID number: 605 207), Dresdner Kleinwort Wasserstein has - on behalf of the syndicate banks Cazenove as Joint Bookrunner and Landesbank Baden-Württemberg as Co-Manager - due to the high demand successfully exercised the green shoe option amounting to just under 960,000 shares from existing ...
mehrNew Data Demonstrate Efficacy of Two Leading Anti-HIV Treatments
Dublin, Ireland, November 21 (ots/PRNewswire) - - New hope for HIV/AIDS patients: APTIVUS(R) outperforms several commonly prescribed drugs in the protease inhibitor (PI) class DUBLIN, Ireland, November 21 /PRNewswire/ -- - Experts Emphasize Need for Effective Therapy in Response to Increased Prevalence of HIV/AIDS throughout Europe At the 10th European AIDS Clinical Society (EACS) conference, experts ...
mehrAPTIVUS(R) Sustains Convincing Anti-HIV Effect Through 48 Weeks
Dublin, Ireland, November 21 (ots/PRNewswire) - - Additional Data Provide Further Guidance on Maximizing Treatment Response with APTIVUS(R) New data presented at the 10th European AIDS Conference (EACS) in Dublin demonstrate that through 48 weeks, APTIVUS(R) (tipranavir) provides a convincing and durable benefit, achieving and maintaining a superior treatment response in patients with resistant HIV.(1) ...
mehrUSU Software AG: Annual Result 2004 and Outlook
Möglingen, Germany (ots) - - Positive consolidated result - Sales higher than expectations - Cost basis reduced considerably In the 2004 financial year, USU Software AG (ISIN DE000A0BVU28) generated a positive consolidated result of TEUR 262 (PY: TEUR 6,870).* At TEUR 18,686, sales were down on the previous year's figure of TEUR 19,059. However, they were slightly higher than expectations. The low ...
mehrEfficacy of Investigational Anti-HIV Agent Tipranavir Demonstrated by New Data
INGELHEIM, Germany,, February 28 (ots/PRNewswire) - - Tipranavir/r More Effective Than Lopinavir/r in Large-Scale Studies of Treatment-Experienced HIV-Positive Patients New data from multiple analyses presented last week at the 12th Conference on Retroviruses and Opportunistic Infections support the efficacy of the investigational non-peptidic protease ...
mehr
BASF grows faster than the market
Ludwigshafen (ots) - - Further strong increase in sales and EBIT before special items - Sales prices increased to reflect higher raw materials costs - Risks due to high raw materials prices - Outlook for full year 2004: - Significant increase in sales and EBIT before special items - Premium will be earned on cost of capital BASF continued on its successful course in the third quarter of 2004 and again posted excellent ...
mehrUSU Software AG publishes half-yearly figures
Moeglingen (ots) - - Sales and earnings in line with forecasts - Cost-cutting measures take effect - Further rise in equity ratio - Liquidity base remains sound - Special distribution expected in Q1 2005 - Company aiming for further profitability growth In the fist six months of the current financial year, USU Software AG generated consolidated net income of TEUR 208. In ...
mehrSalesforce.com Announces Initial Public Offering
SAN FRANCISCO (ots) - (BW)(CA-SALESFORCE.COM)(CRM) Salesforce.com Announces Initial Public Offering; Shares to Trade on the New York Stock Exchange Under Ticker Symbol ''CRM'' Business Editors/High-Tech Writers Salesforce.com, inc. (NYSE:CRM) today announced the initial public offering of 10,000,000 shares of its common stock at a price of $11.00 per share. Salesforce.com has ...
mehrBusiness strong in first quarter - BASF increases sales and earnings
Ludwigshafen, Germany (ots) - - Volume growth in all segments - Chemicals activities improve significantly - Cash flow increases further - High raw materials have negative impact - Outlook for full year 2004: Higher EBIT before special items expected BASF again showed that it can maintain a good course, even in stormy economic weather. "We perform consistently thanks to our ...
mehrUSU Software AG: Annual Result 2003 and Outlook
Möglingen (ots) - - Sales development within expectations - Non-recurring effect through goodwill amortisation - Significant reduction of net loss of the year - Cash and capital investments at EUR 47.8 million - Positive result scheduled for the 2004 financial year USU Software AG achieved consolidated sales of EUR 19.1 million (PY: EUR 19.5 million, pro forma* PY: EUR 24.0 million) in the ...
mehrBASF expects moderate growth in 2004
Ludwigshafen (ots) - - Sales rise substantially in 2003 despite negative currency effects - EBIT before special items higher than in previous year - Fourth quarter substantially better than expected - Cash flow at record level - Agricultural Products & Nutrition increases sales and earnings BASF's figures for 2003 clearly show that the tremendous hard work by the company's ...
mehr
Vorherige13141516171819202122Nächste